No results for ‘’
Sampre Nutritions Ltd
NSE: BSE: 530617
â‚ą13.10
(4.97%)
Tue, 09 Jun 2026, 08:56 am
Market Cap (in Cr)0
PE Ratio0
Dividend0
Consumer Non-Durables
Food: Specialty/Candy
24.5KSampre Nutritions Analysis
dividend
- Unable to evaluate Sampre Nutritions's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Sampre Nutritions's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Sampre Nutritions is profitable, therefore cash runway is not a concern.
- Sampre Nutritions is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (28.9%, greater than 20% of total debt).
- Sampre Nutritions's cash and other short term assets cover its long term commitments.
- Sampre Nutritions's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Debt is not covered by short term assets, assets are 0.7x debt.
- The level of debt compared to net worth has increased over the past 5 years (60.3% vs 188.5% today).
- Interest payments on debt are not well covered by earnings (EBIT is 1.1x annual interest expense, ideally 3x coverage).
- Sampre Nutritions's level of debt (188.5%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
- The tenure for the Sampre Nutritions board of directors is about average.
- Brahma's remuneration is lower than average for companies of similar size in India.
- The average tenure for the Sampre Nutritions management team is over 5 years, this suggests they are a seasoned and experienced team.
- Brahma's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
misc
- Sampre Nutritions is not covered by any analysts.
- Sampre Nutritions has significant price volatility in the past 3 months.
- BSE:530617 has not traded for 15 days.
past
- Sampre Nutritions used its assets more efficiently than the IN Food industry average last year based on Return on Assets.
- Sampre Nutritions's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Sampre Nutritions's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
- Sampre Nutritions's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Sampre Nutritions has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Sampre Nutritions's 1-year earnings growth is negative, it can't be compared to the IN Food industry average.
value
- 530617 outperformed the Food industry which returned 18.8% over the past year.
- 530617 outperformed the Market in India which returned -14.5% over the past year.
- Sampre Nutritions's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Sampre Nutritions's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Sampre Nutritions is overvalued based on assets compared to the IN Food industry average.
- Sampre Nutritions is overvalued based on earnings compared to the IN Food industry average.
- Sampre Nutritions is overvalued based on earnings compared to the India market.
- BSE:530617 is flat (-0.6%) underperforming the Food industry which returned 5% over the past month.
- BSE:530617 is flat (-0.6%) underperforming the market in India which returned 8% over the past month.